Rep. Jake Auchincloss

Maddy summaryHR 5835, the REPO Implementation Act of 2025, establishes a mechanism to use frozen Russian sovereign assets held abroad for Ukraine's benefit. It creates a "Ukraine Support Fund" to hold these assets without confiscation and requires the U.S. Treasury to invest them in U.S. government obligations. The bill mandates quarterly transfers of at least $250 million from the fund to Ukraine for assistance, with final amounts spent when less remains. It also requires the President to report to Congress on Russian assets held by foreign countries (including G7/EU members) and urges diplomatic efforts to secure similar asset repurposing from those nations.

Maddy summaryHR 5736, the PAVE Act, requires Medicare beneficiaries aged 65 and older to receive penicillin allergy verification during their initial preventive physical exam and annual wellness visit. The bill mandates that healthcare providers identify patients reporting a penicillin allergy, evaluate whether the reported reaction was a true allergy, explain the health risks of a false allergy label, and refer to specialists when needed. This verification process, effective January 2027, aims to correct false allergy labels - over 90% of which are inaccurate - improving antibiotic choices and patient outcomes. It directly affects seniors covered by Medicare who have self-reported penicillin allergies, with no cost to patients for this service.

Maddy summaryHRES 795 is a non-binding resolution condemning Hamas for the October 7, 2023, attacks that killed over 1,200 people, took 251 hostages (including Americans), and involved sexual violence. It demands Hamas immediately surrender and release all remaining hostages - specifically noting 48 people still held, including two U.S. citizens. The resolution also affirms Israel’s right to self-defense, calls for humanitarian aid to reach Palestinians, and condemns global antisemitism following the attacks. As a symbolic congressional statement, it does not create new laws or alter policies.

Maddy summaryHR 5705 requires the federal government to reimburse state agencies for funds they use to maintain participation in the WIC program during a government shutdown. It directly affects states that cover WIC costs using their own money when federal funding lapses. The bill establishes a process where states can seek reimbursement from the federal government after the shutdown ends. This ensures states aren’t burdened with costs for a federal funding gap that impacts nutrition assistance for women, infants, and children.

Maddy summaryThis bill requires Medicare, Medicaid, CHIP, and federal employee health plans to cover medically necessary specialized foods, vitamins, and amino acids for people with specific digestive and metabolic conditions. It defines "medically necessary food" as prescribed formulas, vitamins, and amino acids designed for conditions like inherited metabolic disorders, inflammatory bowel disease, and severe food allergies that cannot be managed through regular diet. The bill mandates coverage of these items and necessary equipment for administration (like feeding tubes), with Medicare covering 80% of costs. This would directly benefit thousands of patients who rely on these specialized treatments to avoid serious health complications like malnutrition, hospitalizations, and developmental issues.

Maddy summaryThis bill adds Medicare coverage for multi-cancer early detection screening tests (blood or biological tests analyzing cell-free DNA) starting January 1, 2028. It directly affects Medicare beneficiaries aged 68 and older (starting in 2028, with the age limit increasing by 1 year annually), requiring tests to be FDA-cleared and deemed reasonable/necessary by the Secretary for early cancer detection across multiple organ sites. Payment will initially match current stool DNA test rates before 2031, then shift to a lower rate or new payment system after 2031, with limits preventing more than one test per year. The bill explicitly states it does not alter coverage for existing cancer screenings like breast, colorectal, or prostate cancer tests.

Fair Pay for Federal Contractors Act of 2025 This bill provides back pay to employees of federal contractors who lost pay due to a lapse in appropriations (i.e., government shutdown) in FY2026. Specifically, the bill provides appropriations for federal agencies that are subject to a lapse in appropriations in FY2026 to adjust the price of contracts to compensate federal contractors for providing back pay to employees who were affected by the lapse in appropriations.  The agencies must adjust the price of any contract for which the contractor stopped, suspended, delayed, or interrupted all or part of the work under the contract due to the lapse in appropriations. The price adjustment must compensate the contractor for reasonable costs incurred to (1) compensate employees who were furloughed or laid off, were not working, or experienced a reduction of hours or compensation due to the lapse in appropriations; or (2) restore paid leave taken by employees during the lapse in appropriations if the contractor required or permitted employees to use paid leave as a result of the lapse in appropriations. The maximum amount of weekly compensation of an employee for which an adjustment may be made under this bill may not exceed the lesser of (1) the employee's actual weekly compensation, or (2) $1,442 (or a lesser amount pro-rated for an employee who works less than 40 hours per week). The bill also requires the Office of Federal Procurement Policy to submit a report to Congress on the adjustments made under this bill.

Maddy summaryThis bill requires home medical devices like blood pressure monitors and sleep apnea machines to include nonvisual accessibility features (such as screen readers or audio feedback) so blind or low-vision users can operate them independently and safely. It sets a standard that devices must be as effective for these users as for sighted individuals, applying to Class II/III devices cleared under FDA's 510(k) process for home use. The FDA must issue proposed regulations within one year and final rules within two years of enactment, with manufacturers needing to comply one year after the final rule takes effect. Devices may qualify for waivers only if compliance would cause a "fundamental alteration" or "undue hardship" for the manufacturer, though the bill emphasizes accessibility can often be integrated without extra cost during design.

Maddy summaryHR 5526, the Biosimilar Red Tape Elimination Act, streamlines the U.S. Food and Drug Administration’s (FDA) process for approving biosimilar drugs that can be used interchangeably with brand-name biologic medications. It establishes a 60-day transition period after enactment to clarify when biosimilars are deemed "interchangeable" with reference drugs, preserving existing exclusivity periods for products licensed before the law’s passage. This affects pharmaceutical manufacturers developing biosimilars, the FDA (which must update its guidance within 18 months), and healthcare systems seeking lower-cost treatment options. The bill removes redundant language from existing laws and ensures the FDA’s approval standards for biosimilars remain unchanged, focusing on regulatory clarity rather than altering drug safety or efficacy requirements.

Maddy summaryHRES 746 is a non-binding resolution passed by the U.S. House of Representatives condemning all political violence - including attacks on elected officials, candidates, and public figures - and rejecting rhetoric that dehumanizes opponents. It specifically urges law enforcement to investigate and prosecute such violence, calls on public officials and media to avoid inflammatory language, and references recent incidents like the 2025 assassination of activist Charlie Kirk and targeted shootings of Minnesota legislators. The resolution does not create new laws but formally expresses the House’s commitment to protecting public servants and promoting peaceful political discourse. It directly affects the House’s public stance and serves as a call to action for officials, media, and communities to foster civil engagement.